A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

Acta Psychiatrica Scandinavica

Volumn 96, Issue 4, 1997, Pages 265-273

  Peuskens, J ^a   Link, C G G ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Atypical antipsychotic; Chlorpromazine; Quetiapine; Schizophrenia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BENZATROPINE MESILATE; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CHLORPROMAZINE; DIBENZOTHIAZEPINE DERIVATIVE; GAMMA GLUTAMYLTRANSFERASE; PROLACTIN; QUETIAPINE;

ADULT; AGITATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SOMNOLENCE;

EID: 0030805337     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb10162.x     Document Type: Article

References (22)

1. KANE J, HONIGFIELD G, SINGER J, MELTZER H. Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 1988: 45: 789-796.
2. IDÄNPÄÄN-HEIKKILÄ J, ALHAVA E, OLKINVORA M, PALVA I. Agranulocytosis during treatment with clozapine. Eur J Clin Pharmacol 1977: 11: 193-198.
3. FITTON A, HEEL RC. Clozapine - a review of its pharmacological properties and therapeutic use in schizophrenia. Drugs 1990: 40: 722-747.
4. MELTZER H. The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychiatry 1992: 160: 22-29.
5. SALLER CF, SALAMA AI. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology 1993: 112: 285-292.
6. MELTZER HY, DANIELS S, FANG VS. Clozapine increases rat serum prolactin levels. Life Sci 1975: 17: 339-342.
7. CHIODO LA, BUNNEY BS. Typical and atypical antipsychotics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. Neuroscience 1983: 3: 1607-1619.
8. WHITE FJ, WANG RY. Differential aspects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 1983: 221: 1054-1057.
9. GOLDSTEIN JM, LITWIN LC, SUTTON EB, MALICK JB. Seroquel: electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology 1993: 112: 293-298.
10. CASEY DE. Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 1989: 99: S47-S53.
11. MIGLER BM, WARAWA EJ, MALICK JB. Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drugs. Psychopharmacology 1993: 112: 299-307.
12. FABRE LF. A multicentre open pilot trial of Seroquel in hospitalised patients with acute psychotic symptomatology. Schizophr Res 1993: 9: 237 (abstract).
13. HIRSCH SR, LINK CGG, GOLDSTEIN JM, ARVANITIS LA. Seroquel, a new atypical antipsychotic drug. Br J Psychiatry 1996: 00: 000-000.
14. FABRE LF, ARVANITIS L, PULTZ J, JONES VM, MALICK JB, SLOTNICK MD. Seroquel, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Clin Therapeutics 1995: 17: 366-378.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd edn. Washington, DC: American Psychiatric Association 1987.
16. OVERALL JE, GORHAM DR. BPRS: Brief Psychiatric Rating Scale. In: GUY W, ed. ECDEU assessment manual for psychopharmacology, revised edn. Rockville, MD, USA: Department of Health, Education and Welfare, 1976: 158-169.
17. CGI: Clinical Global Impression. In: Guy W, ed. ECDEU assessment manual for psychopharmacology, revised edn. Rockville, MD, USA: Department of Health, Education and Welfare, 1976: 218-222.
18. BALDESSARINI RJ, COHEN BM, TEICHNER MH et al. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 1988: 45: 79-91.
19. KAY SR, FISZBEIN A, OPLER LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987: 13: 261-276.
20. BARNES TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989: 154: 672-676.
21. AIMS: Abnormal Involuntary Movement Scale. In: GUY W, ed. ECDEU assessment manual for psychopharmacology, revised edn. Rockville, MD, USA: Department of Health, Education and Welfare, 1976: 158-169.
22. SIMPSON GM, ANGUS JWS. A rating scale for extrapyramidal side-effects. Acta Psychiatr Scand 1970: 45 (Suppl. 212): 11-19.